Search

Search Constraints

You searched for: Author/Creator Richman, Laura

Search Results

1. A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. Issue 1 (23rd February 2013)

4. Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies. Issue 4 (April 2014)

5. MicroRNA‐206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. (17th January 2014)

6. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Issue 11 (28th July 2011)

7. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Issue 11 (27th July 2011)